Finance

Lists
Why is PHAT up 3,35%?
Dive Deeper
PHAT:NASDAQ
Phathom Pharmaceuticals Inc
5,25 US$
+3,35%
(+0,17) 1D
5,25 US$
0,00% (0,00)
After hours
Closed: 6 ნოე, 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PHAT...
Open
5,26 US$
High
5,30 US$
Low
5,04 US$
Mkt. cap
426,78 მლნ.
Avg. vol.
1,65 მლნ.
Volume
1,77 მლნ.
52-wk high
18,31 US$
52-wk low
5,02 US$
EPS
-1,03 US$
Beta
0,69
Shares outstanding
81,29 მლნ.
No. of employees
371
Open
5,26 US$
High
5,30 US$
Low
5,04 US$
Mkt. cap
426,78 მლნ.
Avg. vol.
1,65 მლნ.
Volume
1,77 მლნ.
52-wk high
18,31 US$
52-wk low
5,02 US$
EPS
-1,03 US$
Beta
0,69
Shares outstanding
81,29 მლნ.
No. of employees
371
News stories
From web sources and news partners
About Phathom Pharmaceuticals Inc
CEO-
Employees371
Founded2018
HeadquartersFlorham Park, ნიუ-ჯერსი, ამერიკის შეერთებული შტატები
SectorHealth Care
IndustryPharmaceutical industry
Analyst ratings
Based on 6 analysts giving stock ratings to PHAT in the past 3 months
Strong buy
Buy
5
Hold
1
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for PHAT in the last 3 months.
Highest
Current 5,25 US$
26,00 US$ (+395,24%)
Average
16,90 US$ (+221,90%)
Lowest
7,50 US$ (+42,86%)
Analyst
Recommendation
Action
Price target
Projected
Date
Daniel Clark
Leerink Partners
Hold
Maintained
7,50 US$
+42,9%
11/02/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
22,00 US$
+319%
10/29/2026
Matthew Caufield
H.C. Wainwright
Buy
Reiterated
26,00 US$
+395,2%
10/30/2026
Jenna Davidner
Barclays
Buy
Maintained
14,00 US$
+166,7%
10/30/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
-
-
10/23/2026
Chase Knickerbocker
Craig-Hallum
Buy
Maintained
15,00 US$
+185,7%
10/21/2026
Martin Auster
Raymond James
Buy
Maintained
21,00 US$
+300%
07/31/2026
Joseph Stringer
Needham
Buy
Maintained
22,00 US$
+319%
07/30/2026
Paul Choi
Goldman Sachs
Hold
Maintained
-
-
04/30/2026
Last report
29 ოქტ. 2026
Fiscal period
Q3 2026
0,04 US$ / 0,03 US$
+39,86%beat
Revenue / Est. (USD)
84,72 მლნ. / 84,82 მლნ.
-0,12%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
დეკ. 2025
მარ. 2026
ივნ. 2026
სექ. 2026
Revenue
57,58 მლნ.
58,30 მლნ.
74,27 მლნ.
84,72 მლნ.
Cost of goods sold
7,65 მლნ.
12,00 მლნ.
15,10 მლნ.
18,37 მლნ.
Cost of revenue
7,65 მლნ.
12,00 მლნ.
15,10 მლნ.
18,37 მლნ.
Research and development expenses
7,49 მლნ.
7,77 მლნ.
7,81 მლნ.
8,74 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
48,37 მლნ.
54,01 მლნ.
55,33 მლნ.
57,70 მლნ.
Operating expense
55,86 მლნ.
61,78 მლნ.
63,14 მლნ.
66,44 მლნ.
Total operating expenses
63,51 მლნ.
73,78 მლნ.
78,24 მლნ.
84,81 მლნ.
Operating income
-5,93 მლნ.
-15,48 მლნ.
-3,96 მლნ.
-85,00 ათ.
Other non operating income
-5,00 ათ.
-831,00 ათ.
-24,00 ათ.
-25,00 ათ.
EBT including unusual items
-21,15 მლნ.
-30,37 მლნ.
-17,58 მლნ.
-13,90 მლნ.
EBT excluding unusual items
-21,15 მლნ.
-30,37 მლნ.
-17,58 მლნ.
-13,90 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-21,15 მლნ.
-30,37 მლნ.
-17,58 მლნ.
-13,90 მლნ.
Net profit margin
-36,73%
-52,09%
-23,67%
-16,40%
Earnings per share
-0,08
-0,18
-
0,04
Interest and investment income
1,20 მლნ.
1,74 მლნ.
1,51 მლნ.
1,60 მლნ.
Interest expense
-16,42 მლნ.
-15,80 მლნ.
-15,10 მლნ.
-15,39 მლნ.
Net interest expenses
-15,22 მლნ.
-14,06 მლნ.
-13,59 მლნ.
-13,79 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-5,80 მლნ.
-15,37 მლნ.
-3,85 მლნ.
35,00 ათ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google აპები